CT Contrast

 

CT Contrast

 

In computed tomography (CT), intravenous iodinated contrast is used to enhance the image with information on the vascularity and characteristics of organs and pathologic lesions. The iodine density blocks the passage of the x-ray photons, causing the contrast to appear denser (white) on the CT images.

 

There is a low but non-negligible level of risk associated with intravenous iodinated contrast agents. Certain patients may experience severe and potentially life-threatening allergic reactions to the contrast dye.

 

The contrast agent may also induce kidney damage. The risk of this is increased with patients who have preexisting renal insufficiency, preexisting diabetes, or reduced intravascular volume. In general, if a patient has normal kidney function, then the risks of contrast nephropathy are negligible.

Patients with a history of the following are required to have a recent BUN and creatinine to check for kidney function prior to receiving intravenous iodinated contrast.

  • 60 years of age or older
  • Renal disease
  • Diabetes
  • Multiple myeloma
  • Active Gout

When to use CT Contrast


BRAIN

SOFT TISSUE NECK

CHEST

ABDOMEN/PELVIS

CTA

  • Primary brain tumors
  • Metastatic disease
  • Seizures
  • Inflammatory disease
  • Postoperative brain
  • Recurrent tumor
  • Pituitary adenoma
  • Differentiation of microvascular infarction
  • Selected cases of complex vascular disease or stroke
  • All scans

  • Primary lung cancer
  • Metastatic diseases
  • Suspected adenopathy
  • Aortic aneurysm
  • Loculated pleural effusion

 

  • Any vascular studies of the aorta
  • Any vascular branches of the aorta